Mesothelioma Researchers Announce Meaningful Improvement from Pembrolizumab Plus Chemotherapy Treatment
Researchers from Merck, the pharmaceutical company behind the immunotherapy drug pembrolizumab (Keytruda), have announced that first-line treatment that combines their product...
from Mesothelioma.net https://ift.tt/DGWwyAM
via IFTTT
from Mesothelioma.net https://ift.tt/DGWwyAM
via IFTTT
Mesothelioma Researchers Announce Meaningful Improvement from Pembrolizumab Plus Chemotherapy Treatment
![Mesothelioma Researchers Announce Meaningful Improvement from Pembrolizumab Plus Chemotherapy Treatment]()
Reviewed by Unknown
on
March 16, 2023
Rating:
No comments: